Hamilton Medical AG
Hamilton Medical AG, headquartered in Switzerland (CH), is a leading innovator in the medical technology industry, specialising in advanced ventilation solutions. Founded in 1983, the company has established a strong presence in Europe, North America, and Asia, focusing on critical care and anaesthesia. Hamilton Medical is renowned for its cutting-edge ventilators and intelligent ventilation software, which enhance patient outcomes through precision and adaptability. Their flagship products, such as the HAMILTON-G5 and HAMILTON-C6, are distinguished by their unique features, including adaptive support modes and user-friendly interfaces. With a commitment to research and development, Hamilton Medical AG has achieved significant milestones, positioning itself as a trusted partner in hospitals worldwide. The company’s dedication to innovation and quality has earned it a prominent market position, making it a preferred choice among healthcare professionals in critical care settings.
DitchCarbon Score
How does Hamilton Medical AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hamilton Medical AG's score of 34 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Hamilton Medical AG's reported carbon emissions
In 2023, Hamilton Medical AG reported total greenhouse gas emissions of approximately 275,928,000 kg CO2e, which includes Scope 1 emissions of 500,000 kg CO2e, Scope 2 emissions of 1,500,000 kg CO2e, and significant Scope 3 emissions of 273,928,000 kg CO2e. The company has set ambitious near-term targets in line with the Science Based Targets initiative (SBTi), aiming to reduce its absolute Scope 1 and 2 emissions by 42% and Scope 3 emissions by 52% per CHF value added by 2030, using 2020 as the base year. In 2024, Hamilton Medical AG's total emissions increased to about 151,254,000 kg CO2e, although specific breakdowns for Scope 1, 2, and 3 were not disclosed for this year. The company is committed to achieving these reduction targets, which include biogenic land-related emissions and removals from bioenergy feedstocks. Hamilton Medical AG's climate commitments reflect a strong dedication to sustainability within the healthcare equipment and supplies sector, with a clear pathway to significantly lower emissions over the next decade. The targets are designed to align with the global goal of limiting temperature rise to 1.5°C, demonstrating the company's proactive approach to addressing climate change.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2023 | |
|---|---|---|
| Scope 1 | 750,000 | 000,000 |
| Scope 2 | 1,750,000 | 0,000,000 |
| Scope 3 | 273,928,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hamilton Medical AG is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
